Brant Point Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,500
Closed -$2.41M 111
2024
Q2
$2.41M Buy
+7,500
New +$2.44M 0.22% 81
2017
Q1
Sell
-43,000
Closed -$3.18M 142
2016
Q4
$3.18M Hold
43,000
0.31% 86
2016
Q3
$3.25M Sell
43,000
-20,000
-32% -$1.53M 0.29% 80
2016
Q2
$4.85M Hold
63,000
0.46% 51
2016
Q1
$4.92M Hold
63,000
0.51% 47
2015
Q4
$4.26M Sell
63,000
-92,000
-59% -$6.42M 0.49% 53
2015
Q3
$12M Sell
155,000
-5,000
-3% -$443K 1.33% 11
2015
Q2
$14.5M Sell
160,000
-40,000
-20% -$3.2M 1.32% 8
2015
Q1
$15M Buy
200,000
+20,000
+11% +$1.44M 1.35% 9
2014
Q4
$13.2M Buy
180,000
+80,000
+80% +$5.62M 1.23% 10
2014
Q3
$7.05M Hold
100,000
0.67% 42
2014
Q2
$5.64M Buy
+100,000
New +$5.28M 0.51% 59

Other funds holding HCA

Brant Point Investment Management's HCA Position: Q1 2026 in Review

Brant Point Investment Management reduced its HCA Healthcare (HCA) stake by 8.8% in Q1 2026, selling an estimated $408K and leaving 8,419 shares worth $3.98M. The position accounts for 0.51% of the portfolio, ranked #58.

Brant Point Investment Management first reported a position in HCA in Q2 2014 and has held it in 35 quarters since. The position peaked at $11.6M in Q3 2024. 1,418 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Brant Point Investment Management held 8,419 shares of HCA Healthcare worth $3.98M as of Q1 2026.
  • Brant Point Investment Management sold 810 HCA Healthcare shares in Q1 2026, an estimated $408K.
  • HCA Healthcare made up 0.51% of Brant Point Investment Management's portfolio in Q1 2026, its #58 holding.
  • Brant Point Investment Management first reported a position in HCA Healthcare in Q2 2014 and has held it in 35 quarters since.
  • Brant Point Investment Management's HCA Healthcare position peaked at $11.6M in Q3 2024.
  • 1,418 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Brant Point Investment Management's 13F filing for Q1 2026, filed 14 May 2026.